medigraphic.com
ISSN 1995-9427 (Print)

2020, Number 2

<< Back Next >>

Invest Medicoquir 2020; 12 (2)

Tuberculosis. Molecular Epidemiology

Calzado BA, Oliva NN, Vergara ÁR

Language: Spanish
References: 47
Page: 1-17
PDF size: 524.80 Kb.


ABSTRACT

The reemergence of tuberculosis in the world has sparked interest in understanding the epidemiology and pathogenesis of this disease. With the use and establishment of molecular epidemiology as a new discipline, another dimension was added to the classical epidemiology of tuberculosis and the knowledge of the dynamics of transmission of Mycobacterium tuberculosis within a population has increased. The discovery of repetitive deoxyribonucleic acid (DNA) sequences in the Mycobacterium tuberculosis chromosome, such as IS6110, has allowed the development of reliable molecular techniques in the characterization of strains of this species, as well as the determination of lineages and their geographical distribution. In Cuba, it has been useful in the study of outbreaks in closed institutions and in determining the circulating genetic patterns in the country. There are still great challenges that involve incorporating molecular epidemiology in tuberculosis prevention and control programs.


REFERENCES

  1. Arpajón Y, Sosa AL, Doval R Contribuciones de la técnica de la Reacción en Cadenas de la Polimerasa a la Epidemiología Molecular de las enfermedades infecciosas en Cuba. Rev haban cienc méd 2014; 13 (6).

  2. Boccia S, Pasquarella C, Colotto M, Barchitta M, Quattrocchi A, Agodi A, and the Public Health Genomics and GISIO Working Groups of the Italian Society of Hygiene, Preventive Medicine and Public Health (SItI). Molecular epidemiology tools in the management of healthcare-associated infections: towards the definition of recommendations. Epidemiol Prev. 2015; 39 (5): 21-26.

  3. Field N, Cohen T, Struelens MJ, et al. Strengthening the Reporting of Molecular Epidemiology for Infectious Diseases (STROME-ID): an extension of the STROBE statement. Lancet Infect Dis 2014; 14: 341–52.

  4. Struelens MJ, Brisse S. From molecular to genomic epidemiology: transforming surveillance and control of infectious diseases. Euro Surveill 2013;18(4):20386.

  5. Agodi A, Voulgari E, Barchitta M, Quattrocchi A, Bellocchi P, Poulou A, et al. Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals. J Hosp Infect. 2014; 86(4): 260-6. doi: 10.1016/j.jhin.2014.02.001.

  6. Ranjbar R, Karami A, Farshad S, Giammanco GM, Mammina C. Typing methods used in the molecular epidemiology of microbial pathogens: a how-to guide. New Microbiol 2014; 37:1-15.

  7. Sabat AJ, Budimir A, Nashev D, Sá-Leão R, Van Dijl Jm, Laurent F, et al, on behalf of the ESCMID Study Group of Epidemiological Markers (ESGEM). Overview of molecular typing methods for outbreak detection and epidemiological surveillance. Euro Surveill. 2013;18(4):20380.

  8. Marcos V. Burgos 1, Juan Camilo Méndez 1, Wellman Ribon 1,2. Molecular epidemiology of tuberculosis: methodology and applications. Biomédica 2004;24(Supl.):188-201.

  9. Boccia S, Pasquarella C, Colotto M, Barchitta M, Quattrocchi A, Agodi A, and the Public Health Genomics and GISIO Working Groups of the Italian Society of Hygiene, Sujatha Narayanan. Molecular epidemiology of tuberculosis. Indian J Med Res 120, October 2004, pp 233-247.

  10. Daley CL. Molecular epidemiology: a tool for understanding control of tuberculosis transmission. Clin Chest Med. 2005 ;26(2):217-31.

  11. Hernández JE, Murcia MI, de la Hoz F. Epidemiología Molecular de la Tuberculosis en Bogotá en Aislados Clínicos obtenidos durante 11 Años. Rev. salud pública 2008; 10(1).

  12. Murcia MI, Leao SC, Rittaco V, Palenque E, de Oliveira RS, Reniero A, et al. Distribución de patrones PRA en aislamientos clínicos del complejo Mycobacterium avium procedentes de España y Suramérica. Biomédica. 2004; 25: 22-33.

  13. Díaz R, Montoro E, González R, Echemendía M, Valdivia JA. Analysis of Mycobacterium. Tuberculosis strains isolated during an outbreak of HIV-infected patients by DNA fingerprinting. Am J Trop Med Hyg1995;53(2):155-6

  14. Gómez RI, Díaz R, García N, Valdivia JA. Estudio epidemiológico-molecular de un brote de tuberculosis en el hospital psiquiátrico de La Habana. Rev Cubana Hig Epidemiol 2000;38(3).

  15. Díaz R, Gómez RI, García N, Valdivia JA, Soolingen G. Transmission of in Havana, Cuba; a molecular epidemiology study by IS6110 restriction fragment length polymorphism typing. Memorias do Instituto Oswaldo Cruz 2001;96(4):437-43

  16. Diaz R, Kremer K, de Haas PE, Gomez RI, Marrero A, et al. Molecular epidemiology of tuberculosis in Cuba outside of Havana, July 1994-June 1995: utility of spoligotyping versus IS6110 restriction fragment length polymorphism. Int J Tuberc Lung Dis 1998; 2: 743-50.

  17. Jara B, Navarrete O, Abad A, Calvo J, Pérez A, Ramos A. Tuberculosis en la población inmigrante del Área 10 de Madrid. Rev Patol Respir 2006; 9(3): 120-124.

  18. Burgos MV, Pym AS. Molecular epidemiology of tuberculosis. Eur Respir J Suppl. 2002 ;36:54s-65s.

  19. Van Helden P. Molecular Epidemiology of TB: Challenging Dogmas and Asking New Questions. IUBMB Life 2002; 53: 219–223.

  20. Reinfección exógena en un área con moderada incidencia de TB (Las Palmas de Gran Canaria). 1991-1996: AJRCCM 2001; 163: 717-20)

  21. Reinfección exógena en un área con alta incidencia de TB (Sudáfrica) 1992-1998: NEJM 1999; 341: 1174-79.

  22. Wong P, Puray M, Gonzales A, Sevilla CR. Epidemiología molecular de la tuberculosis en el Perú. 2011; 15 (1).

  23. Aranaz A, Romero B, Montero N, Álvarez J, Bezos J, De Juan L, Mateos A, Dominguez L. Spoligotyping Profile Change Caused by Deletion of a Direct Variable Repeat in A Isogenic Mycobacterium tuberculosis. Laboratory Strain. 2004; 42(11): 5388-91.

  24. Spurgiesz RS, Quitugua TN, Smith Kl, Schupp J, Palmer EG, Cox RA, Keim P. Molecular Typing of by Using Nine Novel Variable-Number Tandem Repeats Across the Beijing Family and Low-Copy-Number IS6110 Isolates. 2003; 41(9): 4224-30.

  25. Frothingham R, Meeker-O’Connell WA. Genetic Diversity in The Mycobacterium Tuberculosis Complex Based on Variable Numbers of Tandem DNA Repeats.1998; 144 (5): 1189-96

  26. Moure R, Muñoz L, Torres M, Santin M, Martín R, Alcaide F. Rapid Detection of Mycobacterium Tuberculosis Complex and Rifampin Resistance in Smear-Negative Clinical Samples by use of an Integrated Real-Time PCR Method. 2011; 49(3): 1137-9.

  27. WHO. UNITAID. Tuberculosis Diagnostic Technology and Market Landscape, 3rd edition. Geneva: World Health Organization., 2014. [Internet]. 2014 [Consultado el 23 de agosto de 2017] Disponible en:http://www.unitaid.eu/images/marketdynamics/publications/UNITAID_TB.

  28. Frick M., Lessem E., McKenna L. 2016 pipeline report. Tuberculosis (TB) Edition. Diagnostics, treatment, prevention and vaccines in development. Action Group. London/New York [Internet]. 2016 [Consultado el 23 de agosto de 2017] Disponible en:http://www.pipelinereport.org/sites/g/files/g575521/.

  29. Lienhardt C, Glaziou P, Uplekar M, Lonnroth K, Getahun H, Raviglione M. Global tuberculosis control: lessons learnt and future prospects. Nature reviews. 2012;10(6):407-16.

  30. Brites D, Gagneux S. Co-evolution of Mycobacterium tuberculosis and Homo sapiens. Immunological reviews. 2015;264(1):6-24 Comas I, Homolka Susanne, Niemann Stefan, Gagneux Sebastien. 2009. Genotyping of Genetically Monomorphic Bacteria: DNA Serquencing in Mycobacterium Tuberculosis Highlights the Limitations of Current Methodologies. PLoS ONE, 4(11): e7815

  31. Gagneux S, DeRiemer K, Van T, Kato-Maeda M, de Jong BC, Narayanan S, et al. Variable hostpathogen compatibility in Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences of the United States of America. 2006;103(8):2869-73.

  32. Hershberg R, Lipatov M, Small PM, Sheffer H, Niemann S, Homolka S, et al. High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography. PLoS biology. 2008;6(12): e311.

  33. Brudey K, Driscoll JR, Rigouts L, Prodinger WM, Gori A, Al-Hajoj SA, et al. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC microbiology. 2006; 6:23.

  34. Filliol I, Driscoll JR, Van Soolingen D, Kreiswirth BN, Kremer K, Valetudie G, et al. Global distribution of Mycobacterium tuberculosis spoligotypes. Emerging infectious diseases. 2002;8(11):1347-9.

  35. Tao Luo, Iñaki Comas,Dan Luo, Bing Lu, Jie Wu, Lanhai Wei, Chongguang Yang, Qingyun Liu, Mingyu Gan, Gang Sun, Xin Shen, Feiying Liu, Sebastien Gagneux, Jian Mei, Rushu Lan, Kanglin Wan, and Qian Gao. 2015. Southern East Asian origin and coexpansion of Mycobacterium tuberculosis Beijing family with Han Chinese. PNAS 2015 112 (26) 8136-814.

  36. Morlock GP, Metchock B, Sikes D, Crawford JT, Cooksey RC. Etha, Inha, and Kat G. Loci of Ethionamide-Resistant Clinical Mycobacterium Tuberculosis Isolates. Antimicrob. Agents Chemother 2003; 47: 3799–80.

  37. Jiménez AP. Genotipificación de Mycobacterium tuberculosis complex mediante herramientas moleculares en Ecuador [Tesis para optar por título de Doctor en Ciencias]. Valencia: Universidad Politécnica de Valencia; 2015.

  38. González A, Battaglioli T, Diaz R, Goza R, González Edilberto, Van Der Stuyft P. Molecular Epidemiology of Tuberculosis in Havana, Cuba, 2009.Trop Med Int Health 2015;20 (11):1534-1542.

  39. Casper C, Singh SP, Rane S, Daley CL, Schecter GS, LW, et al. The transcontinental transmission of tuberculosis: a molecular epidemiological assessment. Am J Public Health 1996; 86: 551-3.

  40. Glynn JR, Whiteley J, Bifani PJ, Kremer K, van Soolingen D. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis 2002; 8: 843-9.

  41. Daley CL, Small PM, Schecter GF, Schoolnik GK, McAdam RA, Jacobs WR, Jr., Hopewell PC. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphism. N Engl J Med 1992; 326: 231-5.

  42. Bifani PJ, Plikaytis BB, Kapur V, Stockbauer K, Pan X, Lutfey ML, et al. Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA 1996; 275: 452-7.

  43. Anh DD, Borgdorff MW, Van LN, Lan NT, van Gookom T, Kremer K, et al. Mycobacterium tuberculosis Beijing genotypes emerging in Vietnam. Emerg Infect Dis 2000; 6: 302-5.

  44. Kurepina N, Shashkina E, Sloutsky A, Naroditskaya V, Safonova S, Chernousova L, et al. RFLP and DST data on Mycobacterium tuberculosis cultures isolated from patients in prison and civilian populations in Russia.

  45. Beltrán MY. Genotipificación de Mycobacterium Tuberculosis en aislados clínicos obtenidos de pacientes VIH positivos de los hospitales Simón Bolívar y Santa Clara de Bogotá. [Tesis para optar por título de Máster en Ciencias en Infecciones y Salud en el Trópico Bogotá]. Bogotá: Universidad Nacional de Colombia;2016.

  46. Herrera YM; Fonseca CM; Gozá R; Martínez IM; Lemus D; Llanes MJ; Marrero A; Díaz R. Tipificación con oligonucleótidos espaciadores de Mycobacterium tuberculosis en Cuba. Revista Cubana de Medicina Tropical 2015;67(1):85-96.

  47. Díaz R. Caracterización molecular de cepas de Mycobacterium tuberculosis y su implicación del control de la Tuberculosis en Cuba. [Tesis para optar por título de Doctor en Ciencias]. La Habana: IPK; 2003.




2020     |     www.medigraphic.com